1 manent amenorrhea, temporary amenorrhea, and oligomenorrhea among different regimens; and (4) analyze

2      In affected sisters, only one-half have oligomenorrhea and hyperandrogenemia characteristic of P

3 perprolactinemia, two of whom presented with oligomenorrhea and one with infertility.

4                                     Although oligomenorrhea has been associated cross-sectionally wit

5 us, CRA (early and late), temporary CRA, and oligomenorrhea in the setting of adjuvant treatment.

6 gation of hyperandrogenemia (with or without oligomenorrhea) in PCOS kindreds.

7 glucose intolerance, it is not known whether oligomenorrhea is a marker for increased future risk of

8 te (n = 8, hyperandrogenism), or low (n = 7, oligomenorrhea or amenorrhea) suspicion of PCOS.

9 irls with high (n = 40, hyperandrogenism and oligomenorrhea or amenorrhea), intermediate (n = 8, hype

10 cific symptomatology in these women, such as oligomenorrhea or hirsutism.

11 rs) girls with no clinical hyperandrogenism, oligomenorrhea, or amenorrhea.

12 history elements (eg, fever, hypertrichosis, oligomenorrhea) were important, they regularly failed to